Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
HarvardTrials will no longer be available as of June 7. You can search ClinicalTrials.gov directly for Harvard-sponsored studies. If you have questions, please email us.
Check out the new look and feel of Harvard Catalyst Profiles! Learn more on our About and Help pages.

Monika Anna Niewczas, Ph.D., M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Satake E, Pezzolesi MG, Md Dom ZI, Smiles AM, Niewczas MA, Krolewski AS. Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes. Diabetes. 2018 May; 67(5):1013-1023. PMID: 29453204.
    View in: PubMed
  2. Nowak N, Skupien J, Smiles AM, Yamanouchi M, Niewczas MA, Galecki AT, Duffin KL, Breyer MD, Pullen N, Bonventre JV, Krolewski AS. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development. Kidney Int. 2018 May; 93(5):1198-1206. PMID: 29398132.
    View in: PubMed
  3. Niewczas MA, Krolewski AS. Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390. Diabetes Care. 2017 08; 40(8):e109-e110. PMID: 28733381.
    View in: PubMed
  4. Qi W, Keenan HA, Li Q, Ishikado A, Kannt A, Sadowski T, Yorek MA, Wu IH, Lockhart S, Coppey LJ, Pfenninger A, Liew CW, Qiang G, Burkart AM, Hastings S, Pober D, Cahill C, Niewczas MA, Israelsen WJ, Tinsley L, Stillman IE, Amenta PS, Feener EP, Vander Heiden MG, Stanton RC, King GL. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction. Nat Med. 2017 Jun; 23(6):753-762. PMID: 28436957.
    View in: PubMed
  5. Yamanouchi M, Skupien J, Niewczas MA, Smiles AM, Doria A, Stanton RC, Galecki AT, Duffin KL, Pullen N, Breyer MD, Bonventre JV, Warram JH, Krolewski AS. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease. Kidney Int. 2017 07; 92(1):258-266. PMID: 28396115.
    View in: PubMed
  6. Niewczas MA, Mathew AV, Croall S, Byun J, Major M, Sabisetti VS, Smiles A, Bonventre JV, Pennathur S, Krolewski AS. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care. 2017 03; 40(3):383-390. PMID: 28087576.
    View in: PubMed
  7. Bassi R, Niewczas MA, Biancone L, Bussolino S, Merugumala S, Tezza S, D'Addio F, Ben Nasr M, Valderrama-Vasquez A, Usuelli V, De Zan V, El Essawy B, Venturini M, Secchi A, De Cobelli F, Lin A, Chandraker A, Fiorina P. Metabolomic Profiling in Individuals with a Failing Kidney Allograft. PLoS One. 2017; 12(1):e0169077. PMID: 28052095.
    View in: PubMed
  8. Nowak N, Skupien J, Niewczas MA, Yamanouchi M, Major M, Croall S, Smiles A, Warram JH, Bonventre JV, Krolewski AS. Increased plasma kidney injury molecule-1 suggests early progressive renal decline in non-proteinuric patients with type 1 diabetes. Kidney Int. 2016 Feb; 89(2):459-67. PMID: 26509588; PMCID: PMC4848189.
  9. Pavkov ME, Weil EJ, Fufaa GD, Nelson RG, Lemley KV, Knowler WC, Niewczas MA, Krolewski AS. Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes. Kidney Int. 2016 Jan; 89(1):226-34. PMID: 26398493.
    View in: PubMed
  10. Prudente S, Shah H, Bailetti D, Pezzolesi M, Buranasupkajorn P, Mercuri L, Mendonca C, De Cosmo S, Niewczas M, Trischitta V, Doria A. Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes. Diabetes. 2015 Jul; 64(7):2658-63. PMID: 25677913; PMCID: PMC4477355.
  11. Pavkov ME, Nelson RG, Knowler WC, Cheng Y, Krolewski AS, Niewczas MA. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes. Kidney Int. 2015 Apr; 87(4):812-9. PMID: 25272234.
    View in: PubMed
  12. Kleffel S, Vergani A, Tezza S, Ben Nasr M, Niewczas MA, Wong S, Bassi R, D'Addio F, Schatton T, Abdi R, Atkinson M, Sayegh MH, Wen L, Wasserfall CH, O'Connor KC, Fiorina P. Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens. Diabetes. 2015 Jan; 64(1):158-71. PMID: 25187361; PMCID: PMC4274804.
  13. Skupien J, Warram JH, Niewczas MA, Gohda T, Malecki M, Mychaleckyj JC, Galecki AT, Krolewski AS. Synergism between circulating tumor necrosis factor receptor 2 and HbA(1c) in determining renal decline during 5-18 years of follow-up in patients with type 1 diabetes and proteinuria. Diabetes Care. 2014 Sep; 37(9):2601-8. PMID: 24898299; PMCID: PMC4140154.
  14. Fiorina P, Vergani A, Bassi R, Niewczas MA, Altintas MM, Pezzolesi MG, D'Addio F, Chin M, Tezza S, Ben Nasr M, Mattinzoli D, Ikehata M, Corradi D, Schumacher V, Buvall L, Yu CC, Chang JM, La Rosa S, Finzi G, Solini A, Vincenti F, Rastaldi MP, Reiser J, Krolewski AS, Mundel PH, Sayegh MH. Role of podocyte B7-1 in diabetic nephropathy. J Am Soc Nephrol. 2014 Jul; 25(7):1415-29. PMID: 24676639; PMCID: PMC4073425.
  15. Niewczas MA, Sirich TL, Mathew AV, Skupien J, Mohney RP, Warram JH, Smiles A, Huang X, Walker W, Byun J, Karoly ED, Kensicki EM, Berry GT, Bonventre JV, Pennathur S, Meyer TW, Krolewski AS. Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study. Kidney Int. 2014 May; 85(5):1214-24. PMID: 24429397.
    View in: PubMed
  16. Krolewski AS, Gohda T, Niewczas MA. Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes. Clin Exp Nephrol. 2014 Aug; 18(4):571-83. PMID: 24218296; PMCID: PMC4018428.
  17. Qi L, Qi Q, Prudente S, Mendonca C, Andreozzi F, di Pietro N, Sturma M, Novelli V, Mannino GC, Formoso G, Gervino EV, Hauser TH, Muehlschlegel JD, Niewczas MA, Krolewski AS, Biolo G, Pandolfi A, Rimm E, Sesti G, Trischitta V, Hu F, Doria A. Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. JAMA. 2013 Aug 28; 310(8):821-8. PMID: 23982368; PMCID: PMC3858847.
  18. Krolewski AS, Niewczas MA, Skupien J, Gohda T, Smiles A, Eckfeldt JH, Doria A, Warram JH. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care. 2014; 37(1):226-34. PMID: 23939543; PMCID: PMC3867993.
  19. Lee JE, Gohda T, Walker WH, Skupien J, Smiles AM, Holak RR, Jeong J, McDonnell KP, Krolewski AS, Niewczas MA. Risk of ESRD and all cause mortality in type 2 diabetes according to circulating levels of FGF-23 and TNFR1. PLoS One. 2013; 8(3):e58007. PMID: 23526964; PMCID: PMC3603950.
  20. Wanic K, Krolewski B, Ju W, Placha G, Niewczas MA, Walker W, Warram JH, Kretzler M, Krolewski AS. Transcriptome analysis of proximal tubular cells (HK-2) exposed to urines of type 1 diabetes patients at risk of early progressive renal function decline. PLoS One. 2013; 8(3):e57751. PMID: 23505438; PMCID: PMC3591403.
  21. Merchant ML, Niewczas MA, Ficociello LH, Lukenbill JA, Wilkey DW, Li M, Khundmiri SJ, Warram JH, Krolewski AS, Klein JB. Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes. Kidney Int. 2013 Jun; 83(6):1177-84. PMID: 23466993.
    View in: PubMed
  22. Vergani A, Tezza S, D'Addio F, Fotino C, Liu K, Niewczas M, Bassi R, Molano RD, Kleffel S, Petrelli A, Soleti A, Ammirati E, Frigerio M, Visner G, Grassi F, Ferrero ME, Corradi D, Abdi R, Ricordi C, Sayegh MH, Pileggi A, Fiorina P. Long-term heart transplant survival by targeting the ionotropic purinergic receptor P2X7. Circulation. 2013 Jan 29; 127(4):463-75. PMID: 23250993; PMCID: PMC3569513.
  23. Doria A, Niewczas MA, Fiorina P. Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy? Semin Nephrol. 2012 Sep; 32(5):437-44. PMID: 23062984; PMCID: PMC3474984.
  24. Skupien J, Warram JH, Smiles AM, Niewczas MA, Gohda T, Pezzolesi MG, Cantarovich D, Stanton R, Krolewski AS. The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease. Kidney Int. 2012 Sep; 82(5):589-97. PMID: 22622493; PMCID: PMC3425658.
  25. Perkins BA, Rabbani N, Weston A, Ficociello LH, Adaikalakoteswari A, Niewczas M, Warram J, Krolewski AS, Thornalley P. Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes. PLoS One. 2012; 7(4):e35655. PMID: 22558190; PMCID: PMC3338454.
  26. Gohda T, Walker WH, Wolkow P, Lee JE, Warram JH, Krolewski AS, Niewczas MA. Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes. Am J Physiol Renal Physiol. 2012 Jul 01; 303(1):F157-62. PMID: 22513848; PMCID: PMC3431142.
  27. Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, Cullere X, Eckfeldt JH, Doria A, Mayadas TN, Warram JH, Krolewski AS. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol. 2012 Mar; 23(3):507-15. PMID: 22266663; PMCID: PMC3294310.
  28. Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM, Mayadas TN, Warram JH, Krolewski AS. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol. 2012 Mar; 23(3):516-24. PMID: 22266664; PMCID: PMC3294299.
  29. Engelmann P, Farkas K, Kis J, Richman G, Zhang Z, Liew CW, Borowiec M, Niewczas MA, Jalahej H, Orbán T. Characterization of human invariant natural killer T cells expressing FoxP3. Int Immunol. 2011 Aug; 23(8):473-84. PMID: 21708895.
    View in: PubMed
  30. Rosolowsky ET, Skupien J, Smiles AM, Niewczas M, Roshan B, Stanton R, Eckfeldt JH, Warram JH, Krolewski AS. Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol. 2011 Mar; 22(3):545-53. PMID: 21355053; PMCID: PMC3060448.
  31. Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS, Bonventre JV. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-ß-D-glucosaminidase. Kidney Int. 2011 Feb; 79(4):464-70. PMID: 20980978; PMCID: PMC3033751.
  32. Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS. High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care. 2010 Jun; 33(6):1337-43. PMID: 20332356; PMCID: PMC2875450.
  33. Niewczas MA, Ficociello LH, Johnson AC, Walker W, Rosolowsky ET, Roshan B, Warram JH, Krolewski AS. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2009 Jan; 4(1):62-70. PMID: 19073786; PMCID: PMC2615709.
  34. Rosolowsky ET, Niewczas MA, Ficociello LH, Perkins BA, Warram JH, Krolewski AS. Between hyperfiltration and impairment: demystifying early renal functional changes in diabetic nephropathy. Diabetes Res Clin Pract. 2008 Nov 13; 82 Suppl 1:S46-53. PMID: 18849087.
    View in: PubMed
  35. Rosolowsky ET, Ficociello LH, Maselli NJ, Niewczas MA, Binns AL, Roshan B, Warram JH, Krolewski AS. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2008 May; 3(3):706-13. PMID: 18272826; PMCID: PMC2386694.
  36. Wolkow PP, Niewczas MA, Perkins B, Ficociello LH, Lipinski B, Warram JH, Krolewski AS. Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. J Am Soc Nephrol. 2008 Apr; 19(4):789-97. PMID: 18256362; PMCID: PMC2390964.
  37. Juskowa J, Lewandowska M, Bartlomiejczyk I, Foroncewicz B, Korabiewska I, Niewczas M, Sierdzinski J. Physical rehabilitation and risk of atherosclerosis after successful kidney transplantation. Transplant Proc. 2006 Jan-Feb; 38(1):157-60. PMID: 16504691.
    View in: PubMed
  38. Wyzgal J, Oldakowska-Jedynak U, Paczek L, Michalska M, Ziolkowski J, Soluch L, Zygier D, Sanko-Resmer J, Gradowska L, Niewczas M, Galazka Z, Pacholczyk M, Durlik M. Posttransplantation diabetus mellitus under calcineurin inhibitor. Transplant Proc. 2003 Sep; 35(6):2216-8. PMID: 14529893.
    View in: PubMed
  39. Patkowski W, Nyckowski P, Zieniewicz K, Pawlak J, Michalowicz B, Kotulski M, Smoter P, Grodzicki M, Skwarek A, Ziolkowski J, Oldakowska-Jedynak U, Niewczas M, Paczek L, Krawczyk M. Biliary tract complications following liver transplantation. Transplant Proc. 2003 Sep; 35(6):2316-7. PMID: 14529926.
    View in: PubMed
  40. Ziolkowski J, Paczek L, Niewczas M, Senatorski G, Oldakowska-Jedynak U, Wyzgal J, Foroncewicz B, Mucha K, Zegarska J, Nyckowski P, Zieniewicz K, Patkowski W, Krawczyk M, Ziarkiewicz-Wroblewska B, Gornicka B. Effect of immunosuppressive regimen on acute rejection and liver graft function. Transplant Proc. 2003 Sep; 35(6):2281-3. PMID: 14529915.
    View in: PubMed
  41. Krawczyk M, Grzelak I, Zieniewicz K, Nyckowski P, Pawlak J, Michalowicz B, Patkowski W, Alsharabi A, Wróblewski T, Paluszkiewicz R, Malkowski P, Hevelke P, Pszenny C, Remiszewski P, Skwarek A, Smoter P, Grodzicki M, Kornasiewicz O, Korba M, Kotulski M, Dudek K, Fraczek M, Najnigier B, Alzayany M, Paczkowska A, Gelo R, Andruszkiewicz P, Sicinski M, Jurek-Gelo A, Swierczewski J, Giercuszkiewicz D, Brudkowska A, Andrzejewska R, Niewinski G, Nowak R, Kosinski C, Korta T, Oldakowska-Jedynak U, Sanko-Resmer J, Pawlowska M, Foroncewicz B, Ziólkowski J, Niewczas M, Mucha K, Senatorski G, Paczek L, Leowska E, Pacho R, Andrzejewska M, Rowinski O, Zurakowski J, Wróblewska B, Górnicka B. The impact of experience of a transplantation center on the outcomes of orthotopic liver transplantation. Transplant Proc. 2003 Sep; 35(6):2268-70. PMID: 14529910.
    View in: PubMed
  42. Zieniewicz K, Skwarek A, Nyckowski P, Pawlak J, Michalowicz B, Patkowski W, Najnigier B, Alsharabi A, Hevelke P, Remiszewski P, Smoter P, Dudek K, Grodzicki M, Paczkowska A, Oldakowska-Jedynak U, Niewczas M, Paczek L, Krawczyk M. Comparison of the results of liver transplantation for elective versus urgent indications. Transplant Proc. 2003 Sep; 35(6):2262-4. PMID: 14529908.
    View in: PubMed
  43. Oldakowska-Jedynak U, Niewczas M, Ziolkowski J, Mucha K, Foroncewicz B, Bartlomiejczyk I, Senatorski G, Wyzgal J, Krawczyk M, Zieniewicz K, Nyckowski P, Paczek L. Cytomegalovirus infection as a common complication following liver transplantation. Transplant Proc. 2003 Sep; 35(6):2295-7. PMID: 14529920.
    View in: PubMed
  44. Ziolkowski J, Niewczas M, Senatorski G, Zygier D, Oldakowska-Jedynak U, Wyzgal J, Michalska W, Niemczyk M, Zieniewicz K, Nyckowski P, Alsharabi A, Hevelke P, Krawczyk M, Górnicka B, Ziarkiewicz-Wróblewska B, Paczek L. Liver transplantation in hepatitis C virus-related cirrhosis. Transplant Proc. 2003 Sep; 35(6):2275-7. PMID: 14529913.
    View in: PubMed
  45. Ziolkowski J, Paczek L, Niewczas M, Senatorski G, Oldakowska-Jedynak U, Wyzgal J, Foroncewicz B, Mucha K, Zegarska J, Nyckowski P, Zieniewicz K, Patkowski W, Krawczyk M, Ziarkiewicz-Wroblewska B, Gornicka B. Acute liver transplant rejection: incidence and the role of high-doses steroids. Transplant Proc. 2003 Sep; 35(6):2289-91. PMID: 14529918.
    View in: PubMed
  46. Ziolkowski J, Paczek L, Senatorski G, Niewczas M, Oldakowska-Jedynak U, Wyzgal J, Sanko-Resmer J, Pilecki T, Zieniewicz K, Nyckowski P, Patkowski W, Krawczyk M. Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. Transplant Proc. 2003 Sep; 35(6):2307-9. PMID: 14529923.
    View in: PubMed
  47. Senatorski G, Paczek L, Kropiewnicka E, Wyzgal J, Pilecki T, Zegarska J, Niewczas M. [Noninvasive monitoring of chronic glomerulonephritides progression]. Pol Merkur Lekarski. 2002 Nov; 13 Suppl 1:21-6; discussion 26-7. PMID: 12621777.
    View in: PubMed
  48. Niewczas M, Paczek L, Krawczyk M, Pawlak J, Bartlomiejczyk I, Górnicka B. [Enzymatic activity of cathepsin B, cathepsin B and L, plasmin, trypsin and collagenase in hepatocellular carcinoma]. Pol Arch Med Wewn. 2002 Jul; 108(1):653-62. PMID: 12412410.
    View in: PubMed
  49. Niewczas M, Ziólkowski J, Rancewicz Z, Szymanska K, Kwiatkowski A, Galazka T, Senatorski G, Paczek L. Tuberculosis in patients after renal transplantation remains still a clinical problem. Transplant Proc. 2002 Mar; 34(2):677-9. PMID: 12009662.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Niewczas's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (236)
Explore
_
Co-Authors (30)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_